Results 61 to 70 of about 2,358,294 (308)

Unveiling Kartagener’s Syndrome in a Young Male: A Case Report [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Kartagener's Syndrome (KS) is a rare genetic condition that affects the cilia. It is characterised by a situs inversus triad, chronic sinusitis, and bronchiectasis, distinguishing it from other diseases.
Priyanka Kalpesh Negandhi   +4 more
doaj   +1 more source

The activity of granulocytes in children with recurrent infections of respiratory tract

open access: yesPneumonologia i Alergologia Polska, 2008
Acute upper respiratory tract infection (URTI) is a common disease in young children. URTI contributes to approximately 20% of mortality in children younger than 5 years of age. Infections of the upper respiratory tract are the most common cause of viral morbidity in children.
Barbara, Jakubczak   +2 more
openaire   +2 more sources

PANoptosis in the pathogenesis of myelodysplastic syndromes

open access: yesMolecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla   +4 more
wiley   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

Increased health service use for asthma, but decreased for COPD: Northumbrian hospital episodes, 2013–2014 [PDF]

open access: yes, 2016
The burden of respiratory disease has persisted over the years, for both men and women. The aim of the present study was to investigate the hospital episode rates in respiratory disease and to understand whether and how the use of the health service for ...
Shiue, Ivy, I. Shiue
core   +1 more source

A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections

open access: yesJournal of Translational Medicine, 2019
Over many years, OM-85, a lysate of 21 common bacterial respiratory pathogens, has been demonstrated to prevent respiratory recurrences in children.
S. Esposito   +6 more
semanticscholar   +1 more source

Vitamin D - An Elixir for Recurrent Upper Respiratory Tract Infection

open access: yesIndian Journal of Otolaryngology and Head & Neck Surgery, 2023
The aim of this study was to assess and compare the level of serum vitamin-D in participants affected with recurrent upper respiratory tract infections and in healthy population and to know whether vitamin-D deficiency is factor contributing to recurrent upper respiratory tract infections (URTI).A case control study was conducted on 52 subjects with ...
Maqbool, M A   +2 more
openaire   +2 more sources

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin   +11 more
wiley   +1 more source

Real‐World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity‐Matched Study From the EUSTAR Cohort

open access: yesArthritis Care &Research, EarlyView.
Objective JAK inhibitors (JAKi) have shown promising effects in early‐phase studies of systemic sclerosis (SSc). We aimed to assess the safety and explore the effectiveness of JAKi compared to conventional immunosuppressants in SSc. Methods A longitudinal retrospective study of the European Scleroderma Trials and Research Group (EUSTAR) cohort was ...
Stefano Di Donato   +27 more
wiley   +1 more source

Recurrent upper respiratory tract infections in childhood—a challenge for general practitioners

open access: yes, 2021
Introduction: In childhood, recurrent upper respiratory tract infections are the most common reason for visiting a general practitioner. (GP) The complexity and similarity in the symptoms of these infections are a challenge for their differentiation as ...
Hristova, Eva; Medical University of Varna   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy